Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism

Hirotaka Komaba, Masatomo Taniguchi, Atsushi Wada, Kunitoshi Iseki, Yoshiharu Tsubakihara, Masafumi Fukagawa

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Parathyroidectomy (PTx) drastically improves biochemical parameters and clinical symptoms related to severe secondary hyperparathyroidism (SHPT) but the effect of PTx on survival has not been adequately investigated. Here we analyzed data on 114,064 maintenance hemodialysis patients from a nationwide registry of the Japanese Society for Dialysis Therapy to evaluate the associations of severity of SHPT and history of PTx with 1-year all-cause and cardiovascular mortality. We then compared the mortality rate between 4428 patients who had undergone PTx and 4428 propensity score-matched patients who had not despite severe SHPT. During a 1-year follow-up, 7926 patients of the entire study population died, of whom 3607 died from cardiovascular disease. Among patients without a history of PTx, severe SHPT was associated with an increased risk for all-cause and cardiovascular mortality. However, such an increased risk of mortality was not observed among patients with a history of PTx. In the propensity score-matched analysis, patients who had undergone PTx had a 34% and 41% lower risk for all-cause and cardiovascular mortality, respectively, compared to the matched controls. The survival benefit associated with PTx was robust in several sensitivity analyses and consistent across subgroups, except for those who had persistent postoperative SHPT. Thus, successful PTx may reduce the risk for all-cause and cardiovascular mortality in hemodialysis patients with severe, uncontrolled SHPT.

Original languageEnglish (US)
Pages (from-to)350-359
Number of pages10
JournalKidney International
Volume88
Issue number2
DOIs
StatePublished - Aug 4 2015

Fingerprint

Parathyroidectomy
Secondary Hyperparathyroidism
Renal Dialysis
Survival
Mortality
Propensity Score
Registries
Dialysis
Cardiovascular Diseases
Maintenance

Keywords

  • hemodialysis
  • hyperparathyroidism
  • parathyroid hormone
  • survival

ASJC Scopus subject areas

  • Nephrology

Cite this

Komaba, H., Taniguchi, M., Wada, A., Iseki, K., Tsubakihara, Y., & Fukagawa, M. (2015). Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney International, 88(2), 350-359. https://doi.org/10.1038/ki.2015.72

Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. / Komaba, Hirotaka; Taniguchi, Masatomo; Wada, Atsushi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Fukagawa, Masafumi.

In: Kidney International, Vol. 88, No. 2, 04.08.2015, p. 350-359.

Research output: Contribution to journalArticle

Komaba, H, Taniguchi, M, Wada, A, Iseki, K, Tsubakihara, Y & Fukagawa, M 2015, 'Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism', Kidney International, vol. 88, no. 2, pp. 350-359. https://doi.org/10.1038/ki.2015.72
Komaba, Hirotaka ; Taniguchi, Masatomo ; Wada, Atsushi ; Iseki, Kunitoshi ; Tsubakihara, Yoshiharu ; Fukagawa, Masafumi. / Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. In: Kidney International. 2015 ; Vol. 88, No. 2. pp. 350-359.
@article{69d9e5f706414c8db1cbfc4f1d2aa5f1,
title = "Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism",
abstract = "Parathyroidectomy (PTx) drastically improves biochemical parameters and clinical symptoms related to severe secondary hyperparathyroidism (SHPT) but the effect of PTx on survival has not been adequately investigated. Here we analyzed data on 114,064 maintenance hemodialysis patients from a nationwide registry of the Japanese Society for Dialysis Therapy to evaluate the associations of severity of SHPT and history of PTx with 1-year all-cause and cardiovascular mortality. We then compared the mortality rate between 4428 patients who had undergone PTx and 4428 propensity score-matched patients who had not despite severe SHPT. During a 1-year follow-up, 7926 patients of the entire study population died, of whom 3607 died from cardiovascular disease. Among patients without a history of PTx, severe SHPT was associated with an increased risk for all-cause and cardiovascular mortality. However, such an increased risk of mortality was not observed among patients with a history of PTx. In the propensity score-matched analysis, patients who had undergone PTx had a 34{\%} and 41{\%} lower risk for all-cause and cardiovascular mortality, respectively, compared to the matched controls. The survival benefit associated with PTx was robust in several sensitivity analyses and consistent across subgroups, except for those who had persistent postoperative SHPT. Thus, successful PTx may reduce the risk for all-cause and cardiovascular mortality in hemodialysis patients with severe, uncontrolled SHPT.",
keywords = "hemodialysis, hyperparathyroidism, parathyroid hormone, survival",
author = "Hirotaka Komaba and Masatomo Taniguchi and Atsushi Wada and Kunitoshi Iseki and Yoshiharu Tsubakihara and Masafumi Fukagawa",
year = "2015",
month = "8",
day = "4",
doi = "10.1038/ki.2015.72",
language = "English (US)",
volume = "88",
pages = "350--359",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism

AU - Komaba, Hirotaka

AU - Taniguchi, Masatomo

AU - Wada, Atsushi

AU - Iseki, Kunitoshi

AU - Tsubakihara, Yoshiharu

AU - Fukagawa, Masafumi

PY - 2015/8/4

Y1 - 2015/8/4

N2 - Parathyroidectomy (PTx) drastically improves biochemical parameters and clinical symptoms related to severe secondary hyperparathyroidism (SHPT) but the effect of PTx on survival has not been adequately investigated. Here we analyzed data on 114,064 maintenance hemodialysis patients from a nationwide registry of the Japanese Society for Dialysis Therapy to evaluate the associations of severity of SHPT and history of PTx with 1-year all-cause and cardiovascular mortality. We then compared the mortality rate between 4428 patients who had undergone PTx and 4428 propensity score-matched patients who had not despite severe SHPT. During a 1-year follow-up, 7926 patients of the entire study population died, of whom 3607 died from cardiovascular disease. Among patients without a history of PTx, severe SHPT was associated with an increased risk for all-cause and cardiovascular mortality. However, such an increased risk of mortality was not observed among patients with a history of PTx. In the propensity score-matched analysis, patients who had undergone PTx had a 34% and 41% lower risk for all-cause and cardiovascular mortality, respectively, compared to the matched controls. The survival benefit associated with PTx was robust in several sensitivity analyses and consistent across subgroups, except for those who had persistent postoperative SHPT. Thus, successful PTx may reduce the risk for all-cause and cardiovascular mortality in hemodialysis patients with severe, uncontrolled SHPT.

AB - Parathyroidectomy (PTx) drastically improves biochemical parameters and clinical symptoms related to severe secondary hyperparathyroidism (SHPT) but the effect of PTx on survival has not been adequately investigated. Here we analyzed data on 114,064 maintenance hemodialysis patients from a nationwide registry of the Japanese Society for Dialysis Therapy to evaluate the associations of severity of SHPT and history of PTx with 1-year all-cause and cardiovascular mortality. We then compared the mortality rate between 4428 patients who had undergone PTx and 4428 propensity score-matched patients who had not despite severe SHPT. During a 1-year follow-up, 7926 patients of the entire study population died, of whom 3607 died from cardiovascular disease. Among patients without a history of PTx, severe SHPT was associated with an increased risk for all-cause and cardiovascular mortality. However, such an increased risk of mortality was not observed among patients with a history of PTx. In the propensity score-matched analysis, patients who had undergone PTx had a 34% and 41% lower risk for all-cause and cardiovascular mortality, respectively, compared to the matched controls. The survival benefit associated with PTx was robust in several sensitivity analyses and consistent across subgroups, except for those who had persistent postoperative SHPT. Thus, successful PTx may reduce the risk for all-cause and cardiovascular mortality in hemodialysis patients with severe, uncontrolled SHPT.

KW - hemodialysis

KW - hyperparathyroidism

KW - parathyroid hormone

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84938550943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938550943&partnerID=8YFLogxK

U2 - 10.1038/ki.2015.72

DO - 10.1038/ki.2015.72

M3 - Article

C2 - 25786097

AN - SCOPUS:84938550943

VL - 88

SP - 350

EP - 359

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 2

ER -